Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by juniper88on Jun 28, 2022 8:41am
164 Views
Post# 34786850

RE:RE:RE:RE:RE:OT -- Update on my wife

RE:RE:RE:RE:RE:OT -- Update on my wifeIn October 2017 she was diagnosed with stage IV ovarian cancer.  To make it five years she was given a 5 to 10% chance.  In 2019 she was told she would have 1 year left to live. We have kept fighting, but believe me it is not easy.  We are exhausted.  

We are very grateful for my wife to be able to receive this experimental medication, but this sponsor is super conservative and safety oriented.  They required the patient to do a weekly blood test and physical assesment for the rest of the trial.  For us it means driving to Detroit from Toronto and back once a week.  But even for others living closer by, for patients who are so sick, it becomes a bit much.  I have not seen this in any other trial.  Usually, this is just for the first cycle.


palinc2000 wrote: This is an extraordinary example of what the Will to live can produce fantastic results...Your wife certainly has the Will but also her Will is compounded by your great support...Good luck to both of you


<< Previous
Bullboard Posts
Next >>